NMA urges vaccinated Nigerians not to stop COVID-19 preventive measures

NMA urges vaccinated Nigerians not to stop COVID-19 preventive measures

Prof. Innocent Ujah
President, NMA

The President, Nigerian Medical Association, Prof. Innocent Ujah, has warned the public, especially those who have been vaccinated against COVID-19, not to stop observing preventive measures, thereby carelessly exposing themselves to the infection.

Ujah gave the advice during the 11th Annual Symposium of the Health Writers Association Of Nigeria (HEWAN) on Wednesday in Lagos.

The symposium was themed; “Building Confidence In COVID-19 Vaccines”, and sub themed: Addressing COVID-19 Hesitancy In Nigeria: The Role Of The Media.”

Ujah said that preventive measures should still be adhered to, noting that research was ongoing to ascertain the degree of protection vaccines provide against the virus and transmission.

According to him, there is an urgent need to inoculate more Nigerians against the virus toward achieving herd immunity quickly.

The NMA president noted that the available vaccines in the country was more than the population that had been vaccinated, stressing the need to overcome vaccine hesitancy.

Ujah said that vaccine hesitancy was fueled by mistrust, complacency, fear and misinformation, noting that the media have a role to play in educating the public on the importance of vaccine.

He commended HEWAN for its efforts in disseminating health promotion messages and dispelling rumours and misinformation about the various vaccines.

Ujah appealed to world leaders to ensure equitable access to the vaccine, especially for the most vulnerable people.

According to him, Africa must stop its dependence on other countries for vaccine, noting that the continent must develop vaccine production capacity.

Ujah was represented by Dr Saliu Oseni, Deputy Secretary, Nigerian Medical Association.

Prof. Oyewale Tomori

Also, Prof. Oyewale Tomori, Professor of Virology, called for collaboration between the government and private sector to actualise vaccine production in the country.

Tomori in his speech titled: “Vaccine Production In Nigeria: The Role Of The Government”, said that there was a need for government to remove bureaucracies that hinders synergies in vaccine development.

The virologist appealed that the government should make the facts available to people to enable them decide, bridge mistrust and invest.

Tomori advised the public to maintain all preventive measures and avoid exposure to the virus, adding that these would assist to curtail spread of the virus.

The professor said that people ascribe the vaccine to what it was not supposed to do.   

Mrs Chioma Obinna
President, HEWAN

 

He said the role of the vaccine was to protect a person from getting infected by the virus, and not to stop exposure, noting that the vaccine was internal while exposure was external.

Tomori noted immunity takes at least 10 days before it develops, adding that it was a body reaction.

Commenting, Mrs Chioma Obinna, President of  HEWAN, said that the theme was chosen following continued conspiracy theories around the COVID-19 vaccines and the disease as a whole.

Obinna said that many Nigerians continued to reject the COVID-19 vaccine out of ignorance or based on unconfirmed stories and information they get from social media, friends and family members.

“As responsible health journalists, these and more informed our choice of the topics for this year’s symposium,” she said.

NAN

 

 

About author

You might also like

Work-related accidents, illnesses kill close to 2m people annually – UN warns  

Work-related illnesses and injuries kill nearly two million people annually, largely due to long working hours, the UN said Friday, warning that the pandemic was likely to worsen the situation.

Cholera: NCDC gives update

Total of  22,130 suspected cases, 526 deaths so far reported from 18 states and FCT    No fewer than 22,130 suspected cases including 526 deaths from cholera have been reported

SAM EFERARO THIS WEEK 0 Comments

Drug development the Nigerian way

Policy grants approval based only on safety profile:  Use whether it works or not, as long as it’s safe for human consumption. Manufacturer to conduct clinical trial after drug hits

0 Comments

No Comments Yet!

You can be first to comment this post!

Leave a Reply